See more : Herkules S.A. (HRS.WA) Income Statement Analysis – Financial Results
Complete financial analysis of IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of IOL Chemicals and Pharmaceuticals Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Oak Valley Bancorp (OVLY) Income Statement Analysis – Financial Results
- Biodesix, Inc. (BDSX) Income Statement Analysis – Financial Results
- 49 North Resources Inc. (FNR.V) Income Statement Analysis – Financial Results
- Perfect Group Corp., Ltd (603059.SS) Income Statement Analysis – Financial Results
- Speciality Restaurants Limited (SPECIALITY.NS) Income Statement Analysis – Financial Results
IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex- ibuprofen; and other APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. Its products are used for treatments, which include anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, anti- convulsant, anti-cholelithic, as well as proton pump inhibitor. The company also provides specialty industrial chemicals comprising ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid for use in food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and chemical intermediates industries. IOL Chemicals and Pharmaceuticals Limited was incorporated in 1986 and is headquartered in Ludhiana, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.33B | 22.17B | 21.68B | 19.46B | 18.64B | 16.55B | 9.62B | 7.11B | 5.80B | 3.85B | 5.64B | 4.82B | 4.71B | 3.89B | 3.49B | 3.02B | 3.18B | 2.03B |
| Cost of Revenue | 14.23B | 15.47B | 15.97B | 11.24B | 10.85B | 10.67B | 7.12B | 4.91B | 4.14B | 2.79B | 3.70B | 3.00B | 3.00B | 2.83B | 2.82B | 2.48B | 2.58B | 1.72B |
| Gross Profit | 7.10B | 6.70B | 5.72B | 8.22B | 7.79B | 5.88B | 2.51B | 2.20B | 1.67B | 1.05B | 1.94B | 1.82B | 1.71B | 1.06B | 677.58M | 541.04M | 602.83M | 309.99M |
| Gross Profit Ratio | 33.28% | 30.22% | 26.37% | 42.24% | 41.80% | 35.53% | 26.05% | 30.93% | 28.74% | 27.42% | 34.35% | 37.70% | 36.27% | 27.24% | 19.39% | 17.92% | 18.96% | 15.30% |
| Research & Development | 0.00 | 167.50M | 111.40M | 74.70M | 67.60M | 58.70M | 32.90M | 29.60M | 10.90M | 14.11M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 66.90M | 58.30M | 45.00M | 40.50M | 24.40M | 14.60M | 10.10M | 9.31M | 7.13M | 248.19M | 541.18K | 446.67K | 0.00 | 45.40M | 38.80M | 36.13M | 28.30M | 20.65M |
| Selling & Marketing | 512.50M | 618.50M | 668.40M | 507.80M | 484.50M | 466.10M | 258.10M | 0.00 | 0.00 | 5.80K | 112.69M | 233.59M | 0.00 | 174.52M | 140.91M | 96.69M | 124.43M | 60.31M |
| SG&A | 2.03B | 676.80M | 713.40M | 548.30M | 508.90M | 480.70M | 268.20M | 9.31M | 7.13M | 248.20M | 398.30M | 234.04M | 0.00 | 219.92M | 179.71M | 132.82M | 152.74M | 80.96M |
| Other Expenses | 0.00 | 256.10M | 33.10M | 12.70M | 14.80M | 7.40M | 1.29B | 180.00K | 180.00K | 180.00K | 180.00K | 180.00K | 1.24B | 382.24M | 202.65M | 148.05M | 128.57M | 66.40M |
| Operating Expenses | 2.20B | 4.91B | 3.56B | 2.69B | 2.41B | 2.11B | 1.56B | 1.48B | 1.45B | 1.23B | 1.29B | 1.24B | 1.24B | 602.16M | 382.36M | 280.87M | 308.56M | 156.47M |
| Cost & Expenses | 16.39B | 20.38B | 19.52B | 13.93B | 13.25B | 12.78B | 8.68B | 6.39B | 5.59B | 4.02B | 4.99B | 4.24B | 4.24B | 3.44B | 3.20B | 2.76B | 2.89B | 1.87B |
| Interest Income | 139.90M | 167.30M | 180.40M | 159.70M | 52.50M | 14.40M | 11.80M | 10.94M | 11.99M | 12.49M | 12.57M | 11.96M | 13.32M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 161.00M | 164.70M | 24.30M | 9.40M | 160.10M | 466.50M | 590.00M | 503.68M | 454.35M | 540.90M | 603.44M | 572.40M | 431.98M | 367.97M | 148.67M | 149.20M | 129.58M | 66.46M |
| Depreciation & Amortization | 629.10M | 461.60M | 432.60M | 389.20M | 357.30M | 324.50M | 302.10M | 298.40M | 296.86M | 289.11M | 316.30M | 313.74M | 239.36M | 237.63M | 100.11M | 100.02M | 74.29M | 34.89M |
| EBITDA | 2.61B | 2.51B | 2.76B | 6.16B | 5.90B | 4.20B | 1.26B | 1.03B | 514.63M | -55.04M | 970.57M | 890.59M | 709.32M | 673.37M | 395.33M | 360.19M | 367.54M | 188.35M |
| EBITDA Ratio | 12.22% | 11.33% | 13.17% | 31.41% | 31.39% | 25.09% | 12.58% | 12.11% | 6.31% | 1.96% | 16.99% | 18.50% | 15.07% | 17.87% | 11.31% | 11.93% | 11.56% | 9.30% |
| Operating Income | 4.94B | 1.80B | 2.16B | 5.53B | 5.38B | 3.77B | 908.50M | 54.77M | -385.50M | -754.38M | 50.82M | 29.58M | 469.96M | 458.40M | 295.21M | 260.17M | 294.27M | 153.52M |
| Operating Income Ratio | 23.17% | 8.12% | 9.97% | 28.42% | 28.88% | 22.79% | 9.44% | 0.77% | -6.64% | -19.61% | 0.90% | 0.61% | 9.98% | 11.77% | 8.45% | 8.62% | 9.26% | 7.58% |
| Total Other Income/Expenses | -3.13B | -2.83B | -2.25B | -1.63B | -49.90M | -411.40M | -586.60M | -1.75B | -531.09M | -542.84M | -973.25M | -547.64M | -431.98M | 3.89B | -148.67M | -149.20M | -130.60M | -66.53M |
| Income Before Tax | 1.82B | 1.89B | 2.25B | 5.71B | 5.33B | 3.36B | 313.00M | 54.77M | -385.50M | -754.38M | 50.82M | 29.58M | 37.98M | 90.43M | 146.54M | 110.98M | 163.67M | 86.99M |
| Income Before Tax Ratio | 8.52% | 8.51% | 10.37% | 29.36% | 28.61% | 20.31% | 3.25% | 0.77% | -6.64% | -19.61% | 0.90% | 0.61% | 0.81% | 2.32% | 4.19% | 3.68% | 5.15% | 4.29% |
| Income Tax Expense | 472.20M | 495.10M | 571.80M | 1.27B | 1.72B | 994.50M | 36.00M | 12.50M | 14.76M | -87.87M | 17.83M | 13.70M | -9.56M | 28.64M | 46.38M | -15.97M | 40.03M | 11.49M |
| Net Income | 1.34B | 1.39B | 1.68B | 4.45B | 3.61B | 2.37B | 277.00M | 42.28M | -400.26M | -666.51M | 32.99M | 15.89M | 47.53M | 61.79M | 100.16M | 126.94M | 123.63M | 75.51M |
| Net Income Ratio | 6.30% | 6.28% | 7.73% | 22.84% | 19.39% | 14.30% | 2.88% | 0.59% | -6.90% | -17.32% | 0.59% | 0.33% | 1.01% | 1.59% | 2.87% | 4.21% | 3.89% | 3.73% |
| EPS | 22.90 | 23.70 | 28.56 | 76.21 | 63.51 | 42.11 | 4.93 | 0.83 | -7.60 | -16.72 | 1.21 | 0.61 | 1.85 | 2.52 | 4.69 | 8.18 | 10.26 | 9.18 |
| EPS Diluted | 22.90 | 23.70 | 28.56 | 76.21 | 63.38 | 42.11 | 4.93 | 0.83 | -7.60 | -16.63 | 1.21 | 0.61 | 1.83 | 2.52 | 4.68 | 7.87 | 7.60 | 9.18 |
| Weighted Avg Shares Out | 58.71M | 58.71M | 58.71M | 58.33M | 56.89M | 56.21M | 56.21M | 56.21M | 52.67M | 39.86M | 27.22M | 26.11M | 25.72M | 25.72M | 21.36M | 15.52M | 12.05M | 8.23M |
| Weighted Avg Shares Out (Dil) | 58.71M | 58.71M | 58.71M | 58.33M | 57.01M | 56.21M | 56.21M | 56.21M | 52.67M | 40.07M | 27.22M | 26.11M | 25.97M | 25.72M | 21.41M | 16.14M | 16.28M | 8.23M |
Source: https://incomestatements.info
Category: Stock Reports